How Abbott’s Continuous Glucose Monitoring System Joined the COVID-19 Fight

Via MDDI Online

“Abbott said it has partnered with the American Diabetes Association, Insulin for Life USA, and the Diabetes Disaster Response Coalition to donate 25,000 FreeStyle Libre 14-day sensors to U.S. hospitals and medical centers in outbreak hotspots to help accelerate access to the technology.”

“According to a recent report from the Centers for Disease Control and Prevention, more than 50% of people with diabetes who have been diagnosed with COVID-19 are hospitalized.”

Read more about how Abbott is working to keep patients with diabetes out of the hospital during COVID-19

MAA COVID-19 INFORMATION DISCLAIMER:

The Medical Alley Association is providing COVID-19 related information, including the “COVID-19 Resource Connect” feature on its website and summaries of laws, executive orders, and government programs that may be of interest to members, as a public service.   The Medical Alley Association makes no representations, guarantees, or warranties as to the accuracy, completeness, currency, or suitability of the COVID-19 related information provided by the Medical Alley Association on its website, in newsletters, or in any other communications. The Medical Alley Association specifically disclaims any and all liability for any claims or damages that may result from providing COVID-19 related information online or in other communications or linking to third party websites or other sources of information. The Medical Alley Association makes no effort to independently verify, and does not exert editorial control over, information provided by third parties.  

The Medical Alley Association does not endorse any of the products, vendors, consultants, or documentation referenced in, or connected to parties through, the COVID-19 Resource Connect feature or via email or other communications.

Keep your finger on the pulse of Medical Alley from anywhere with the ALLEY NEWSLETTER